These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Uptake and binding of liposomal 2',3'-dideoxycytidine by RAW 264.7 cells: a three-step process. Makabi-Panzu B; Lessard C; Beauchamp D; Désormeaux A; Poulin L; Tremblay M; Bergeron MG J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):227-35. PubMed ID: 7859133 [TBL] [Abstract][Full Text] [Related]
3. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Anderson M; Omri A Drug Deliv; 2004; 11(1):33-9. PubMed ID: 15168789 [TBL] [Abstract][Full Text] [Related]
4. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein. Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207 [TBL] [Abstract][Full Text] [Related]
5. Comparison of cellular accumulation, tissue distribution, and anti-HIV activity of free and liposomal 2',3'-dideoxycytidine. Makabi-Panzu B; Lessard C; Perron S; Désormeaux A; Tremblay M; Poulin L; Beauchamp D; Bergeron MG AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1463-70. PubMed ID: 7888201 [TBL] [Abstract][Full Text] [Related]
6. Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate. Beck Z; Matyas GR; Alving CR Biochim Biophys Acta; 2015 Mar; 1848(3):775-80. PubMed ID: 25511587 [TBL] [Abstract][Full Text] [Related]
7. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration. Chaudhury A; Das S; Lee RF; Tan KB; Ng WK; Tan RB; Chiu GN Int J Pharm; 2012 Jul; 430(1-2):167-75. PubMed ID: 22537806 [TBL] [Abstract][Full Text] [Related]
8. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer. Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of vinblastine into transfersomes and liposomes in response to a transmembrane ammonium sulfate gradient and their cytotoxic/cytostatic activity in vitro. Maswadeh H; Demetzos C; Dimas K; Hatziantoniou S; Georgopoulos A; Rallis M; Dallas P; Papaioannou G Anticancer Res; 2001; 21(4A):2577-83. PubMed ID: 11724324 [TBL] [Abstract][Full Text] [Related]
10. Influence of cholesterol on liposome stability and on in vitro drug release. Briuglia ML; Rotella C; McFarlane A; Lamprou DA Drug Deliv Transl Res; 2015 Jun; 5(3):231-42. PubMed ID: 25787731 [TBL] [Abstract][Full Text] [Related]
11. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge. Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629 [TBL] [Abstract][Full Text] [Related]
12. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies. Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683 [TBL] [Abstract][Full Text] [Related]
13. The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization. Chang SF; Yeh CC; Chen PJ; Chang HI Molecules; 2018 Jan; 23(1):. PubMed ID: 29301300 [TBL] [Abstract][Full Text] [Related]
14. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent. Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941 [TBL] [Abstract][Full Text] [Related]
15. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy. Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944 [TBL] [Abstract][Full Text] [Related]
16. Triggered liposomal release through a synthetic phosphatidylcholine analogue bearing a photocleavable moiety embedded within the sn-2 acyl chain. Bayer AM; Alam S; Mattern-Schain SI; Best MD Chemistry; 2014 Mar; 20(12):3350-7. PubMed ID: 24615893 [TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577 [TBL] [Abstract][Full Text] [Related]
18. Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomes. Kim S; Scheerer S; Geyer MA; Howell SB J Infect Dis; 1990 Sep; 162(3):750-2. PubMed ID: 2167343 [TBL] [Abstract][Full Text] [Related]
19. Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro. Chen J; Lin A; Chen Z; Wang W; Zhang T; Cai H; Cai B Drug Dev Ind Pharm; 2010 Mar; 36(3):245-53. PubMed ID: 19678739 [TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice. Hostetler KY; Korba BE; Sridhar CN; Gardner MF Antiviral Res; 1994 May; 24(1):59-67. PubMed ID: 7944313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]